Hepatocellular Carcinoma (HCC) is a type of malignant solid tumor, causing high morbidity and mortality around the world and the major portion of HCC patients is from China. Cancer immunotherapies have shown some clinical responses in treating some types of cancer but did not shown significant efficiency in HCC treatment. This in part due to the impact of immune cells in the tumor microenvironment. It is commonly believed that HCC is a heterogeneous solid tumor and the microenvironment of HCC plays an important role in tumorgenesis and development. Currently, the residents of the microenvironment of HCC is not well-defined and clarification, especially the immune cells, which we believe that paly pivotal roles in tumorgenesis and development. To depict the landscape of the composition, lineage and functional states of the immune cells in HCC, we performed single-cell RNA sequencing on Diethylnitrosamine (DEN)-induced mouse HCC model. We observed heterogeneity within the immune and hepatocytes both in the precancerous condition of tumorigenesis and cancerous condition of HCC. In this study we found that the disease-associated changes appeared early in pathological progression and were highly cell-type specific. Specific subsets of T and B cells preferentially enriched in HCC, and we identified signature genes for each subset. Additionally, we mapped this group of specific cells to the human TCGA database. We found a cluster of naïve B cells characterized by high expression of CD38 associated with better prognosis of human HCC. Our study demonstrates signaling interaction map based on receptor-ligand bonding on the single-cell level could broaden our comprehending of cellular networks in varies status. Our finding provides a new approach for patient stratification and will help further understand the functional states, dynamics and signaling interaction of B cells in hepatocellular carcinoma, and may provide a novel insight and therapeutics for the HCC.
Introduction
More than 50% of the worldwide cases of hepatocellular carcinoma (HCC) occur in China, and this malignancy currently solid tumor represents the country's second leading cause of cancer death [1] . Recent studies have indicated that despite the lack of uniform efficacies among patients in different cancer types, cancer immunotherapies have dramatic impact on the oncological treatment outcomes in colon, lung, breast cancers and melanoma [2, 3] . In contrast, there has been a lack of clinical success in HCC therapies [4] due to the strong dependence on the amount and status of the immune cells in the HCC compliant tumor microenvironment (TME). Recent advances in this area has demonstrated a number of factors that correlate with clinical responses for check point therapies [5] . Unfortunately, these results haven't been conclusive and have not been further developed to be applied as clinical biomarkers. It has been demonstrated that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis by Lars Zender group [6] . To this end, detailed understanding of various immune cells in the community is crucial for the development of effective HCC immunotherapies and the identification of novel biomarkers. In particular, it is also pivotal to explore the composition and status of the immune cells during tumorigenesis. T cells and B cells are the most abundant and best-characterized population in the TME of solid tumors. Studies demonstrated that HCC tumor microenvironment (TME) harbor a significant level of T cells [7] , while those TILs are incapable of killing tumor cells.
The ecosystem of liver tissue include hepatocyte, endothelial, fibroblasts, epithelial, immune cells and many other diverse cell lineages. Tumor formation requires the coordinated function and crosstalk between specific cell types in this distinct ecosystem.
Immune cells migrate from hematopoietic organs to the liver and establish an active immune niche that interacts with stromal cells, influencing differentiation, tumorigenesis and development. At the same time, development of the cells in liver into specialized cells is a highly regulated process. Within a specific microenvironment, dominant signal transmitting cells determine the cellular composition and characteristics by secretion of protein signal. Therefore, The TME of HCC could be an appealing model to characterize the dysregulation and cross talk of various cells.
Single-cell RNA sequencing (scRNA-seq) provides an efficient method to study the cellular heterogeneity of the HCC, by profiling tens of thousands of individual cells [8, 9] simultaneously in the highly complex TME. Traditional bulk-tissue-level resolution may mask the complexity of alterations across cells and within cell groups, especially for less abundant cell types [10] . Potential changes in cell composition during HCC tumorgenesis will also confound the distinction between composition and changes in activity in a given cell type. Thus scRNA-seq profiling of cells enables the decomposition of cell types experimentally and ascertain which of these features may predict or explain clinical responses to anticancer agents. Recently study in Melanoma has shown that this approach when applied to characteristic cells from melanoma patients was able to reveal the exhaustion signature of T cell [12] .
Most human liver cancer studies are cross-sectional at specific given time point and thus unable to provide good characterization of tumorgenesis, such as the dynamics, status and transformation of the cancer development. To begin addressing some of these limitation, we design a study based on DEN induced mice that enable the comparison between the early and late stage of cancer development. This is an initial attempt to capture the dynamics of the cell types and status during the tumorigenesis and development. Note that, DEN model is a well-established chemical induced model that could mimic human HCC [13] . The DEN induction is the most commonly used method in chemically induced liver cancer models, because DEN is metabolized in the liver, it is most effective at inducing liver tumors.
In this study, the single-cell RNA-seq examine >8,000 cells isolated from DEN induced mice enabling us to simultaneously study their transcriptomes. We identified 36 unique cell subsets with distinct tissue distribution patterns, status and interactions. This large-scale transcriptome data of immune cells, especially the transition of status of T cells and B cells and the correlation between immune and hepatocytes can be used as a profitable resource for profiling the characteristics of immune cells and for providing novel insight and approach into HCC prevention and treatment. Moreover, the complex interplay within and across cell types, further contributes to the difficulty in interpreting tissue-resolution signatures of HCC.
Our single-cell transcriptomic resource provides a blueprint for interrogating the molecular and cellular basis of HCC .   R  e  s  u  l  t  s   L  a  n  d  s  c  a  p  e  o  f  t  h  e  c  e  l  l  c  o  m  p  o  s  i  t  i  o  n  a  n  d  c  h  a  r  a  c  t  e  r  i  z  a  t  i  o  n  d  u  r  i  n  g  D  E  N  -i  n  d  u  c  e  d   L i v e r c a n c e r .
To depict the landscape of the composition, lineage and functional states of the immune cells in hepatocellular carcinoma (HCC) tumorgenesis and development, we systematically study the composition and characteristics of different immune and non-immune cell types and status for HCC tumorigenesis by perform single-cell profiling of tumorigenesis and tumor microenvironment.
We collected DEN-induced 6-month and 16-month mouse liver tissue, and we observed that 6 months were pre-cancerous (or early-stage HCC pathology) and 16 months were cancer (or late-stage HCC pathology) (SI- Fig 1) . We can see a large group of inflammatory cells were recruited in the pre-cancer (or early-stage HCC pathology). The tumor tissue of the 16M cancer mouse were liquefactive necrosis at the same time, the adjacent tissue Unsupervised clustering analysis with the most highly variable genes (see Methods) reveal distinct patterns of cell clustering at two levels and differential expression analysis and differential variation analysis were used to facilitate with cell type annotation. We are able to annotate the cluster into 10 main groups: T cell, B cell, Neutrophil cell, Hepatocyte, Dendritic Cell, Endothelial, Epithelial, Fibroblast, Erythrocyte (Fig 1a, SI-Fig 2) .
This indicates that in the HCC tumorgenesis and development, there was a large amount of immune cell (78.9%) infiltration in addition to liver cells. The presence of a small group of erythrocyte (0.2%) indicate that maybe some blood residual in the liver. Furthermore, we found that the cell type compositions are more similar for samples within the same time point than between early and late stage tumorigenesis. In particular, the proportions of T cell and DC significantly increase (p-value from scDC < 0.001, see Method) in the late samples ( Fig 2) . The proportions of Neutrophil cell, Hepatocyte, Endothelial, Epithelial and Fibroblast decreased in the late stage.
We performed unsupervised clustering of each cell types to discover further structure using the spectral clustering method implemented in Seurat [14] . This refined result generated a total of 36 subgroups ( The pattern of hepatocyte shifts tempestuously not only from early to late stage but also between tumor and adjunct. A group of hepatocyte characterized by Afp+ subsets is accumulate in late stage, especially in tumor. These findings suggest that hepatocyte could transfer from Afp-to Afp+ in tumorgenesis and Afp+ hepatocyte is tumor-resident hepatocyte might be release cytokine to immune cells (Fig 3) .
There were three subsets of liver cells during precancer stage and the response patterns were different, whereas it was more uniform in cancer stage, on the other side, there also many Afp-liver cells in the cancer stage. All these indicate that in the inflammation environment the liver cell demonstrated high heterogeneity. GPC3 also shares same pattern. In previous study based on bulk sequencing, we believe that of the Afp is negative in the precancer stage.
In our study, we demonstrated that some cells in the early stage could also express Afp at a single cell resolution. This might be an indication of early cancer screening. We also found that the liver stem cell marker Met is highly expression in the early stage while Thy-1 does not demonstrate significant difference between the two stages. We observe that intra-tumoral T cell clusters are characterized by diverse patterns of environmental signatures. Our findings suggest that tumor-resident T cells might be exposed to varying degrees of inflammation, hypoxia, and nutrient deprivation. While many of these responses (e.g., activation or hypoxia) individually represent phenotypic continuums, their combinations may result in more discrete states. Figure 5 shows that regulatory T cells (T6)
were mostly observed among the CD4+ subset and were defined by the co-expression of CD25 and Foxp3. PD-1+cells were mainly observed in CD8+ subsets, especially in Exhausted CD8+T cell (T0) and naïve T cell (T3). The subset T0, characterized by the highest level of PD-1 expression among CD8+cells, was also positive for other co-inhibitory receptor HAVCR2, the activation markers CD38 and the co-stimulatory receptors such as TNFRSF9 and ICOS. This phenotype was associated with exhausted T cells and anti-PD-1 treatment response [19, 20] . Subsets with similar levels of PD-1 differed in expression of activation markers and co-stimulatory receptors. The cluster T3 had the same expression pattern as T0 but the activation markers and co-stimulatory markers were expressed at lower levels. The other PD-1+clusters (T2, T5 and T7) were characterized by the absence of HAVCR2 expression and by heterogeneity in expression of markers such as TNFRSF9, CTLA-4 and CD38. Unlike Cd4+ Regulatory T cells (T6) presented in the early stage, PD-1+ clusters were mainly present in late stage, but both of them did not show significant difference between tumor and adjacent tissue ( Fig 5) . To understand the interactions between various cells in the HCC microenvironment of the DEN-induced mice thoroughly, we employed a ligand-receptor interacting repository which accounts for their subunit architecture (www.CellPhoneDB.org). This repository comprehend ligand-receptor interaction by the diffusion of secreted molecules [21, 22] . We To compare the cell type proportion between the primary solid tumor samples and normal solid tissue samples of human, we used the single-cell RNA-seq data to decompose the cell types of the TCGA LIHC bulk RNA-seq data (see Method). We have found that statistically significant differences of proportion exist in several cell types (Fig 7) , such as memory B cell (B2), Dendritic cell (DC2) and Afp+ hepatocyte (H3), suggesting scRNA-seq could demonstrate more detail information, and dig out the information that concealed in "average expressing" pattern. And also some clusters share same pattern with the bulk sequencing data (Red asterisk: Bulk data is consistent with scRNA-Seq data; Blueline: Bulk asterisk is different from scRNA-Seq data) tested by Wilcoxon Rank Sum test [22] . To obtain a global understanding of the relationships between all immune populations and clinical outcome, we applied a Cox proportional hazards model that included age, gender, tumor stage in addition with the proportion of certain cell type in the sample (Fig 7b) . We observed correlation In particular, we found that the patients with higher proportion of Exhausted CD8+T cell (T0), MAIT (T1), naïve B cell (B0) have higher chance of survival, while lower proportion of Cd38+T cell (T2), naïve T cell (T3) and Irf8+T cell (T5) has higher survival rate.
Discussion
ScRNA-seq provides an cutting edge method to study the cellular heterogeneity of the tumor microenvironment of many cancer types, by profiling the transcriptomics of thousands level of individual cells [8, 9] . Bulk-tissue-level resolution may mask the complexity of alterations across cells and within cell groups, especially for less abundant cell types [24] . With the development of the higher resolution technology and careful design study design, we are witnessing more and more evidence supporting a role for B cells in tumor immunology. Recently, it has been reported that the presence of tumor-infiltrating B lymphocytes has been linked to favorable clinical outcome in many types of cancers [25] .
However, B cells represent a heterogeneous population with functionally distinct subsets, and the dynamic transition process among subtypes impacts tumor development. B cell-associated autoimmune responses have been commonly found in various tumor types. A wide range of autoantibodies is found to be as markers or as direct mediators of paraneoplastic syndromes [26] , whereas autoimmune diseases are associated with increased or reduced risk of cancer is unclear. Recently, Joseph group demonstrated that cancer can trigger acquired humoral immunity, showing that the appearance of certain autoantibodies is part of a defensive (although eventually unsuccessful in some cases) immune response against a developing tumor [27] . Autoantibodies have attracted interest as potential biomarkers for early diagnosis or for their potential as prognostic indicators for many types of cancer [26] .
It has been proved that the autoantibodies of tumor associated B cells has become potential biomarkers for early diagnosis or for their potential as prognostic indicators for many types of cancer. Although the mechanism through which autoantibody responses are triggered, particularly against commonly expressed proteins, such as glycolytic enzymes, is not well understood. The basic function of the immune system is to discriminate self from non-self.
Since immune tolerance against self-antigens is a highly regulated process, the presence of autoantibodies may signal either breakdown of immune tolerance or that some self-antigens are not encountered by immune cells in nonpathologic states because of their intracellular turnover and limited accessibility in nonmalignant cells [28] . Self-antigens reactivity was not only a dominant characteristic in tumor-bearing mice samples but also in prediagnostic human samples [29] . The evolution in autoantibody reactivity during tumorgenesis and development further demonstrates the dynamics of the autoantibody response. Some cancer-associated autoantibodies are triggered by cellular proteins that are mutated, modified, or aberrantly expressed in tumor cells and hence are regarded as specific "immunological reporters" [30] . The concept that new antigenic epitopes may arise from protein processing has both diagnostic and therapeutic relevance [30] .
The gene signatures of B-cell, especially B-TILs, have been associated with a favorable prognosis for several cancer types, including breast and ovarian [31, 32] . Schmidt group demonstrated that the presence of B-TILs has been linked to a favorable clinical outcome, including breast cancer and NSCLC [28, 33, 34] . These studies have corroborated that the presence of B cells, as derived from gene expression signatures, is linked to a favorable prognosis in breast cancer [32] . Concordantly, immunohistochemical staining of CD20 as a surrogate marker for B cells was found to have prognostic significance for B-TILs in breast cancer [28, 34] . And CD20 is the marker of naïve B cell. CD20 become low expression after naïve B cell matures. But the relationship between naïve B and prognosis of HCC has not been elicited before our study. Our group is the first one who established the naïve B cell is positively correlated with the prognosis in HCC.
B cells represent a heterogeneous population with functionally distinct subsets, contributing to both protumor as well as antitumor immune responses, and the balance among the subtypes may affect tumor development and behavior [35, 36] .Previous study demonstrated that B cells in the tumor microenvironment is related to immune responses. But recent evidences show that B cells have the capacity to recognize antigens, regulate antigen processing and presentation, and mount and modulate T-cell and innate immune responses [28] . The tumor microenvironment contains a heterogeneous population of B cells with functionally distinct subsets, the collaboration of these responses contributing to both pro-immune as well as anti-immune function. In our study, the heterogeneity of B cells and the increase in late T cell suggesting B cells may regulate the quantity and status of T cells.
Apart from the immune-regulatory function of antibody and antibody-antigen complexes, B cells can shape the functions of other immune cells by presenting antigens, providing co-stimulation, and secreting cytokines [37] . The antigen-antibody interactions in this study may, in part, on the extent of provide some evidence for dynamic changes in autoantibody reactivity of B cells contribute to tumor development and progression. in red blood cell lysis buffer (Solarbio) and incubated on ice for 5 min to lyse red blood cells.
METHOD DETAILS
After washing twice with 1 × PBS, the cell pellets were re-suspended in buffer. Quality Control and Preprocessing -The cells were selected by performing empty Dropsto distinguish gene expression profiles that were significantly different to ambient expression profiles. In addition, we used k-means clustering on total expression and mitochondrial proportion to select the set of cells that are likely to be damaged (characterized by very high mitochondrial proportion). We further filtered the cells based on the total number of counts, total number of features, and mitochondrial proportion. After the quality control, 17493 genes and 8821 cells were used for downstream analysis. We then performed SAVER to impute the data to recover the gene expression from the dataset.
Hematoxylin & Eosin
Clustering and cell type identification -To identify and annotate the cell type from the data, we performed clustering analysis using Seurat on the first 20 principal components (PCs), which based on a shared nearest neighbored modularity optimization algorithm, with the resolution parameter as 0.8. Then we performed differential expression analysis using MAST and differential variability analysis using Bartlett test to identify the markers for each cluster, resulting to 10 main cell types in total. We further performed clustering analysis using Seurat, and differential expression analysis within each main cell type to identify sub clusters. Then the weights of the edges between each pair of cell types is determined by the number of the significant ligand-receptor pairs.
Cell type differential composition analysis

Integration with TCGA data and survival analysis
We used the single-cell RNA-seq data to decompose the cell types of the TCGA LIHC bulk RNA-seq data using dtangle. We compared the cell type proportion between the primary Supplementary Information - Table 1 Parameters of each sample.
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